2,084
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Edaravone prevents high glucose-induced injury in retinal Müller cells through thioredoxin1 and the PGC-1α/NRF1/TFAM pathway

&
Pages 1231-1242 | Received 25 Mar 2021, Accepted 20 Aug 2021, Published online: 10 Sep 2021

References

  • Abu El-Asrar AM, Desmet S, Meersschaert A, Dralands L, Missotten L, Geboes K. 2001. Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol. 132(4):551–556.
  • Ago T, Yeh I, Yamamoto M, Schinke-Braun M, Brown JA, Tian B, Sadoshima J. 2006. Thioredoxin1 upregulates mitochondrial proteins related to oxidative phosphorylation and TCA cycle in the heart. Antioxid Redox Signal. 8(9–10):1635–1650.
  • Antonetti DA, Klein R, Gardner TW. 2012. Diabetic retinopathy. N Engl J Med. 366(13):1227–1239.
  • Anuradha CD, Kanno S, Hirano S. 2001. Oxidative damage to mitochondria is a preliminary step to caspase-3 activation in fluoride-induced apoptosis in HL-60 cells. Free Radic Biol Med. 31(3):367–373.
  • Arroba AI, Mazzeo A, Cazzoni D, Beltramo E, Hernández C, Porta M, Simó R, Valverde ÁM. 2016. Somatostatin protects photoreceptor cells against high glucose-induced apoptosis. Mol Vis. 22:1522–1531.
  • Boynton GE, Stem MS, Kwark L, Jackson GR, Farsiu S, Gardner TW. 2015. Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure. Ophthalmology. 122(5):957–967.
  • Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, Osborne NN, Reichenbach A. 2006. Müller cells in the healthy and diseased retina. Prog Retin Eye Res. 25(4):397–424.
  • Brownlee M. 2005. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 54(6):1615–1625.
  • Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. 2002. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes. 51(6):1938–1948.
  • Chaum E. 2003. Retinal neuroprotection by growth factors: a mechanistic perspective. J Cell Biochem. 88(1):57–75.
  • Chavira-Suárez E, Sandoval A, Quintero H, Bustamante P, Felix R, Lamas M. 2012. Hyperglycemia induces early upregulation of the calcium sensor KChIP3/DREAM/calsenilin in the rat retina. Biochem Biophys Res Commun. 418(2):420–425.
  • Chen B, Nelin VE, Locy ML, Jin Y, Tipple TE. 2013. Thioredoxin-1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol. 305:L389– L395.
  • Das AV, Mallya KB, Zhao X, Ahmad F, Bhattacharya S, Thoreson WB, Hegde GV, Ahmad I. 2006. Neural stem cell properties of Müller glia in the mammalian retina: regulation by Notch and Wnt signaling. Dev Biol. 299(1):283–302.
  • Dunn LL, Buckle AM, Cooke JP, Ng MK. 2010. The emerging role of the thioredoxin system in angiogenesis. Arterioscler Thromb Vasc Biol. 30(11):2089–2098.
  • Förstermann U. 2008. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med. 5(6):338–349.
  • Ha H, Lee HB. 2000. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int Suppl. 77:1523–1755.
  • Hironaka K, Inokuchi Y, Fujisawa T, Shimazaki H, Akane M, Tozuka Y, Tsuruma K, Shimazawa M, Hara H, Takeuchi H. 2011. Edaravone-loaded liposomes for retinal protection against oxidative stress-induced retinal damage. Eur J Pharm Biopharm. 79(1):119–125.
  • Hou R, Shen M, Wang R, Liu H, Gao C, Xu J, Tao L, Yin Z, Yin T. 2020. Thioredoxin1 inactivation mediates the impairment of ischemia-induced angiogenesis and further injury in diabetic myocardium. J Vasc Res. 57(2):76–85.
  • Huang OS, Tay WT, Ong PG, Sabanayagam C, Cheng CY, Tan GS, Cheung GC, Lamoureux EL, Imai S, Inokuchi Y, et al. 2010. Systemic administration of a free radical scavenger, edaravone, protects against light-induced photoreceptor degeneration in the mouse retina. Eur J Pharmacol. 642(1–3):77–85.
  • Kowluru RA, Koppolu P. 2002. Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Radic Res. 36(9):993–999.
  • Kuhrt H, Wurm A, Karl A, Iandiev I, Wiedemann P, Reichenbach A, Bringmann A, Pannicke T. 2008. Müller cell gliosis in retinal organ culture mimics gliotic alterations after ischemia in vivo. Int J Dev Neurosci. 26(7):745–751.
  • Laurent T, Moore E, Reichard P. 1964. Enzymatic synthesis of deoxyribonucleotides. iv. isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli b. J Biol Chem. 239:3436–3444.
  • Le YZ. 2017. VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases. Vision Res. 139:108–114.
  • Lee HB, Yu MR, Yang Y, Jiang Z, Ha H. 2003. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol. 14(8 Suppl 3):S241–S245.
  • Levine RL, Wehr N, Williams JA, Stadtman ER, Shacter E. 2000. Determination of carbonyl groups in oxidized proteins. Methods Mol Biol. 99:15–24.
  • Li N, Frigerio F, Maechler P. 2008. The sensitivity of pancreatic beta-cells to mitochondrial injuries triggered by lipotoxicity and oxidative stress. Biochem Soc Trans. 36(Pt 5):930–934.
  • Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, Strother JM. 1998. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes. 47(5):815–820.
  • Lu J, Holmgren A. 2014. The thioredoxin antioxidant system. Free Radic Biol Med. 66:75–87.
  • Luan R, Liu S, Yin T, Lau WB, Wang Q, Guo W, Wang H, Tao L. 2009. High glucose sensitizes adult cardiomyocytes to ischaemia/reperfusion injury through nitrative thioredoxin inactivation. Cardiovasc Res. 83(2):294–302.
  • Ly JD, Grubb DR, Lawen A. 2003. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis. 8(2):115–128.
  • Malone JI, Morrison AD, Pavan PR, Cuthbertson DD. 2001. Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years' duration screened for the diabetes control and complications trial. Diabetes Care. 24(3):522–526.
  • Mizutani M, Gerhardinger C, Lorenzi M. 1998. Müller cell changes in human diabetic retinopathy. Diabetes. 47(3):445–449.
  • Nanjaiah H, Vallikannan B. 2019. Lutein upregulates the PGC-1α, NRF1, and TFAM expression by AMPK activation and downregulates ROS to maintain mtDNA integrity and mitochondrial biogenesis in hyperglycemic ARPE-19 cells and rat retina. Biotechnol Appl Biochem. 66(6):999–1009.
  • Rolo AP, Palmeira CM. 2006. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 212(2):167–178.
  • Rösen P, Nawroth PP, King G, Möller W, Tritschler HJ, Packer L. 2001. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev. 17(3):189–212.
  • Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann JA, Mentzer A, Feldman EL. 2002. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J. 16(13):1738–1748.
  • Shimazaki H, Hironaka K, Fujisawa T, Tsuruma K, Tozuka Y, Shimazawa M, Takeuchi H, Hara H. 2011. Edaravone-loaded liposome eyedrops protect against light-induced retinal damage in mice. Invest Ophthalmol Vis Sci. 52(10):7289–7297.
  • Simó R, Hernández C, European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) 2012. Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications. Br J Ophthalmol. 96(10):1285–1290.
  • Umemura T, Tasaki M, Kijima A, Okamura T, Inoue T, Ishii Y, Suzuki Y, Masui N, Nohmi T, Nishikawa A. 2009. Possible participation of oxidative stress in causation of cell proliferation and in vivo mutagenicity in kidneys of gpt delta rats treated with potassium bromate. Toxicology. 257(1–2):46–52.
  • Verma A, Rani PK, Raman R, Pal SS, Laxmi G, Gupta M, Sahu C, Vaitheeswaran K, Sharma T. 2009. Is neuronal dysfunction an early sign of diabetic retinopathy? Microperimetry and spectral domain optical coherence tomography (SD-OCT) study in individuals with diabetes, but no diabetic retinopathy. Eye. 23(9):1824–1830.
  • Verzola D, Bertolotto MB, Villaggio B, Ottonello L, Dallegri F, Frumento G, Berruti V, Gandolfo MT, Garibotto G, Deferrari G. 2002. Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells. J Investig Med. 50(6):443–451.
  • Wang J, Xu X, Elliott MH, Zhu M, Le YZ. 2010. Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes. 59(9):2297–2305.
  • Weng D, Lu Y, Wei Y, Liu Y, Shen P. 2007. The role of ROS in microcystin-LR-induced hepatocyte apoptosis and liver injury in mice. Toxicology. 232(1–2):15–23.
  • Xu YP, Han F, Tan J. 2017. Edaravone protects the retina against ischemia/reperfusion‑induced oxidative injury through the PI3K/Akt/Nrf2 pathway. Mol Med Rep. 16(6):9210–9216.
  • Yoshida H, Yanai H, Namiki Y, Fukatsu-Sasaki K, Furutani N, Tada N. 2006. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev. 12(1):9–20.
  • Zhang L, Wang J, Chen Y, Zeng L, Li Q, Liu Y, Wang L. 2018. Thioredoxin-1 protects bone marrow-derived mesenchymal stromal cells from hyperoxia-induced injury in vitro. Oxid Med Cell Longev. 2018:1023025.